Randomized Evaluation of Operating Room Extubation After Cardiac Surgery
Randomized Evaluation of Operating Room Extubation Versus Intensive Care Unit Extubation After Cardiac Surgery
We are studying whether waking patients up and removing the breathing tube (also known as "extubation") in the operating room after cardiac surgery improves postoperative recovery without causing harm.
研究概览
详细说明
This is a pragmatic, randomized controlled trial comparing OR extubation versus ICU extubation among adults undergoing elective cardiac surgery.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Lauren Gibson, MD
- 电话号码:617-726-3030
- 邮箱:legibson@mgh.harvard.edu
研究联系人备份
- 姓名:Jordan Bloom, MD, MPH
- 电话号码:617-643-6058
- 邮箱:jpbloom@mgh.harvard.edu
学习地点
-
-
Massachusetts
-
Boston、Massachusetts、美国、02114
- 招聘中
- Massachusetts General Hospital
-
接触:
- Jordan Bloom, MD, MPH
- 电话号码:617-643-6058
- 邮箱:jpbloom@mgh.harvard.edu
-
接触:
- Lauren Gibson, MD
- 邮箱:legibson@mgh.harvard.edu
-
Boston、Massachusetts、美国、02115
- 尚未招聘
- Brigham and Women's Hospital
-
接触:
- Chinyere Archie, MBBS
- 电话号码:617-732-8210
- 邮箱:carchie1@bwh.harvard.edu
-
接触:
- Margaret Connolly, MD
- 邮箱:mrconnolly@mgb.org
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Adults (age 18+) scheduled for elective cardiac surgery requiring cardiopulmonary bypass
- Low perioperative risk defined as STS Predicted Risk of Mortality (PROM) ≤ 3% based on the latest STS Adult Cardiac Surgery Database (ACSD) Risk Calculator
- Deemed appropriate for OR extubation preoperatively by the attending cardiac surgeon
- Able to provide informed consent
Exclusion Criteria:
- Underlying pulmonary disease requiring use of home supplemental oxygen
- Pre-capillary pulmonary hypertension (mPAP ≥ 25 mmHg or PVR > 2 Wood units) on most recent right heart catheterization for any patient for which there is suspicion for pulmonary hypertension at the time of preoperative evaluation
- Preoperative right ventricular dysfunction greater than mild on most recent echocardiogram
- BMI ≥ 35
- Obstructive sleep apnea with home CPAP or biPAP use or recommended use
- Neuromuscular disease associated with respiratory muscle weakness including myasthenia gravis, Lambert-Eaton myasthenic syndrome, or muscular dystrophy
- Airway abnormalities including tracheostomy, history of difficult mask ventilation, history of difficult intubation requiring fiberoptic rescue or multiple (>2) attempts, known anatomic abnormalities including limited mouth opening (< 3cm), severe micrognathia, tracheal stenosis, or tracheal compression due to mass or goiter
We will also exclude patients undergoing the following procedures:
- Transplant surgery
- Pulmonary thromboendarterectomy
- Implantation of mechanical circulatory support including LVAD, Impella, intra-aortic balloon pump, RVAD, or ECMO
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:OR extubation
Extubation in the operating room (OR) at the conclusion of cardiac surgery |
Immediate extubation in the operating room (OR) at the conclusion of cardiac surgery |
|
安慰剂比较:ICU extubation
Extubation in the intensive care unit (ICU) within 6 hours of leaving the OR |
Extubation in the intensive care unit (ICU) within 6 hours of leaving the operating room after cardiac surgery |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Hierarchical composite endpoint, ordered by clinical priority
大体时间:15 days postoperatively
|
|
15 days postoperatively
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Postoperative ICU length of stay
大体时间:30 days
|
Cumulative length of stay (hours) in an intensive care unit (ICU) following cardiac surgery |
30 days
|
|
Postoperative hospital length of stay
大体时间:30 days
|
Length of index hospitalization (hours) following cardiac surgery |
30 days
|
|
Use of non-invasive respiratory support
大体时间:48 hours
|
Use of non-invasive respiratory support such as biPAP, CPAP, or high flow oxygen after OR exit |
48 hours
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.